Role of soluble urokinase-type plasminogen activator receptor in renal diseases
10.16571/j.cnki.1008-8199.2018.07.020
- VernacularTitle: 可溶性尿激酶型纤溶酶原激活物受体在肾疾病中的研究进展
- Author:
Yu-jing ZHOU
1
;
Xiao-yan XIAO
Author Information
1. Department of Endocrinology, 2
- Publication Type:Journal Article
- Keywords:
soluble urokinase-type plasminogen activator receptor;
kidney disease;
biomarker
- From:
Journal of Medical Postgraduates
2018;31(7):768-772
- CountryChina
- Language:Chinese
-
Abstract:
Soluble urokinase-type plasminogen activator receptor(suPAR) , a new injury biomarker, is widely used in research of infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, etc. In recent years, suPAR has been suggested to play an important role in various renal diseases. This review focuses on studies of suPAR in renal diseases and update, which will provide new clues for the diagnosis and treatment of renal diseases.